A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT01572519 · COMPLETED
Trial details
- NCT number
- NCT01572519
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-17
- Primary completion
- 2013-08-13
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.